Mannatech Inc
MTEX- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001056358
No open-market purchases or sales by Mannatech Inc insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $790.9K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Mannatech Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Mannatech Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Haider Yasir | Chief Financial Officer | – | Jun 18, 2026 | 1 |
| Toth Robert | Director | 95,920 | Jun 5, 2026 | 2 |
| John Seifrick A | Director | 13,746 | Jun 5, 2026 | 2 |
| Jobe Larry A | Director | 70,000 | May 21, 2026 | 3 |
| Robbins Kevin Andrew | Director | 33,333 | May 20, 2026 | 2 |
| Fredrick J Stanley | Director | 361,765 | Jan 6, 2026 | 1 |
| Rameson Tyler | Director | 306,673 | Jan 6, 2026 | 1 |
| Clavijo James | Chief Financial Officer | – | Aug 28, 2025 | 0 |
| Barta Erin Kemmler | General Counsel | 3,000 | Aug 28, 2025 | 0 |
| Fredrick Landen Granvel | President and CEO | 12,162 | Aug 28, 2025 | 0 |
| Bala Alfredo | CEO and President | 3,137 | Aug 30, 2023 | 0 |
| Schrier Eric W | Director | 19,118 | Jan 5, 2022 | 0 |
| Johnson David Allen | Chief Financial Officer | 12,500 | Nov 24, 2021 | 0 |
| Norman Ronald Dale | Sr VP Treasury | 6,030 | Sep 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing) | May 20 | 1 day | Jobe Larry ADirector | PPurchaseCommon stock, par value $0.0001 | +2.80K | $4.12 | +$11.5K | +4.2%70.0K after | |
| May 20, 2026 (view filing) | May 19 | 1 day | Jobe Larry ADirector | PPurchaseCommon stock, par value $0.0001 | +5.00K | $4.20 | +$21.0K | +8.0%67.2K after | |
| May 20, 2026 (view filing) | May 19 | 1 day | Robbins Kevin AndrewDirector | PPurchaseCommon stock, par value $0.0001 | +7.10K | $4.17 | +$29.6K | +27.1%33.3K after | |
| Sep 10, 2024 (view filing) | Sep 9 | 1 day | Jobe Larry ADirector | SSaleCommon Stock Par Value $0.0001 Per Share | −16.3K | $7.75 | −$126.2K | −22.9%54.7K after | |
| Sep 10, 2024 (view filing) | Sep 9 | 1 day | Rameson TylerDirector | PPurchaseCommon Stock, par value $0.0001 per share | +16.3K | $7.75 | +$126.2K | +5.8%299.2K after | |
| May 23, 2024 (view filing) | May 22 | 1 day | Jobe Larry ADirector | SSaleCommon Stock Par Value $0.0001 Per Share | −1.01K | $7.60 | −$7.69K | −1.4%71.0K after | |
| Aug 30, 2023 (view filing) | Aug 30 | Same day | Bala AlfredoCEO and President | SSaleCommon Stock, par value $0.0001 per share | −1.00K | $12.40 | −$12.4K | −24.2%3.14K after | |
| Aug 21, 2023 (view filing) | Aug 18 | 3 days | Jobe Larry ADirector | SSaleCommon Stock Par Value $0.0001 Per Share | −1.22K | $12.82 | −$15.6K | −1.8%67.1K after | |
| Jul 6, 2023 (view filing) | Jun 29-30 | 7 daysLate | Bala AlfredoCEO and President | SSaleCommon Stock, par value $0.0001 per share | −269 | $12.77 | −$3.44K | −6.1%4.14K after | 2 lots |
| Dec 29, 2022 (view filing) | Dec 21 | 8 daysLate | Bala AlfredoCEO and President | SSaleCommon Stock, par value $0.0001 per share | −3.50K | $19.69 | −$68.9K | −44.3%4.41K after | |
| Dec 12, 2022 (view filing) | Dec 8 | 4 days | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −1.50K | $22.00 | −$33.0K | −11.5%11.5K after | |
| Mar 30, 2022 (view filing) | Mar 28 | 2 days | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −1.10K | $36.57 | −$40.2K | −7.8%13.0K after | |
| Aug 24, 2021 (view filing) | Aug 23 | 1 day | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −1.50K | $32.99 | −$49.5K | −15.6%8.12K after | |
| Aug 24, 2021 (view filing) | Aug 20 | 4 days | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −1.00K | $32.24 | −$32.2K | −9.4%9.62K after | |
| Aug 20, 2021 (view filing) | Aug 19 | 1 day | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −500 | $31.99 | −$16.0K | −4.5%10.6K after | |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −11 | $31.99 | −$351.89 | −0.1%11.1K after | |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Robbins Kevin AndrewDirector | SSaleCommon Stock Par Value $0.0001 Per Share | −2.00K | $30.83 | −$61.7K | −15.2%11.1K after |